TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...
TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ... TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...
1.309 Zollner-Schwetz I et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis 2008;47:e74-8. 1.310 Guerrant RL et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-50. 1.311 DuPont HL. Bacterial diarrhea. N Engl J Med 2009;361:1560-9. 1.312 Musher DM et al. Contagious gastro-intestinal infections. N Engl J Med 2004;351:2417-27. 1.313 Thielman NM et al. Acute infectious diarrhea. N Engl J Med 2004;350:38-47. 1.314 O‘Ryan M et al. An update on management of severe acute infectious gastroenteritis in children. Expert Rev Anti Infect Ther 2010;8:671-82. 1.315 Phavichitr N et al. Acute gastroenteritis in children: what role for antibacterials? Pediatr Drugs 2003; 5:279-90. 1.316 Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am 2005;19:585-602. 1.317 Chao HC et al. Bacterial enteric infections in children: etiology, clinical manifestations and antimicrobial therapy. Expert Rev Anti Infect Ther 2006;4:629-38. 1.318 Elliott EJ. Acute gastroenteritis in children. Br Med J 2007;334:35-40. 1.319 Barclay AR et al. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007;45:569-76. 1.320 Moss RL et al. Laparatomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med 2006;354:2225-34. 1.321 Flake AW. Necrotizing enterocolitis in preterm infants. Is laparatomy necessary? N Engl J Med 2006; 354:2275-76. 1.322 Sears CL et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008;47:797-803. 1.323 Tribble DR et al. Traveler‘s diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007; 44:338-46. 1.324 DuPont HL. Azithromycin for the self-treatment of traveler‘s diarrhea. Clin Infect Dis 2007;44:347-9. 1.325 Shlim DR. Update in traveler‘s diarrhea. Infect Dis Clin North Am 2005;19:137-49. 1.326 Diemert DJ. Prevention and self-treatment of traveler‘s diarrhea. Clin Microbiol Rev 2006;19:583-94. 1.327 DuPont HL. Therapy for and prevention of traveler‘s diarrhea. Clin Infect Dis 2007;45(suppl. 1):S78- 84. 1.328 Sanders JW et al. Azithromycin and loperamide are similar to levofloxacin and loperamide for the treatment of traveler‘s diarrhea in military personnel in Turkey. Clin Infect Dis 2007;45:294-301. 1.329 Okhuysen PC. Current concepts in traveler‘s diarrhea: epidemiology, antimicrobial resistance and treatment. Curr Opin Infect Dis 2005;18:522-6. 1.330 Leggat PA et al. Thavellers‘ diarrhoea: health advice for travellers. Travel Med Infect Dis 2004;2:17- 22. 1.331 Koo HL et al. Current and future developments in traveler‘s diarrhea therapy. Expert Rev Anti Infect Ther 2006;4:417-27. 1.332 Yates J. Traveler‘s diarrhea. Am Fam Physician 2005;71:2095-100. 1.333 Al-Abri SS et al. Traveller‘s diarrhoea. Lancet Infect Dis 2005;5:349-60. 1.334 Adachi JA et al. Empirical antimicrobial therapy for traveler‘s diarrhea. Clin Infect Dis 2000;31:1079- 83. 1.335 Sack DA et al. Cholera. Lancet 2004;363:223-33. 1.336 Kartalija M et al. Diarrhea and AIDS in the era of highly active antiretroviral therapy. Clin Infect Dis 1999;28:701-7. 1.337 Peghini PL et al. Improvement of chronic diarrhea after treatment for intestinal spirochetosis. Dig Dis Sci 2000;45:1006-10. 1.338 Brooke CJ et al. In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrob Agents Chemother 2003;47:2354-7. 1.339 Koteish A et al. Colonic spirochetosis in children and adults. Am J Clin Pathol 2003;120:828-32. 1.340 Evans MR et al. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection. Clin Infect Dis 2009;48:1500-6. 1.341 Ternhag A et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis 2007;44:696-700. 1.342 Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimi-crobial resistance: playing chicken. Clin Infect Dis 2007;44:701-3. 1.343 Lecuit M et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004;350:239-48. 1.344 Feodoroff FB et al. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. Clin Microbiol Infect 2009;15:188-92. 1.345 Rogers TJ et al. Therapeutic strategies for shigatoxin-producing Escherichia coli infections. Expert Rev Anti Infect Ther 2009;7:683-6. 1.346 Palermos MS et al. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert Rev Anti Infect Ther 2009;7:697-707. 1.347 Goldwater PN. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome. Expert Rev Anti Infect Ther 2007;5:653-63. 1.348 Tarr PI et al. Shiga toxin producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-86. 1.349 Thorpe CM. Shiga toxin producing Escherichia coli infection. Clin Infect Dis 2004;38:1298-303. 1.350 Tzipori S et al. Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 2004;17:926-41. 1.351 Orth D et al. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Expert Rev Anti Infect Ther 2008;6:101-8. 1.352 Majowicz SE et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 2010;50:882-9. 1.353 Saha D et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med 2006;354: 2452-62. 1.354 Abraham C et al. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78. 1.355 Eckburg PB et al. The role of microbes in Crohn‘s disease. Clin Infect Dis 2007;44:256-62. 1.356 Collins P et al. Ulcerative colitis: diagnosis and management. Br Med J 2006;333:340-3. 1.357 Feller M et al. Long-term antibiotic treatment for Crohn‘s disease: systematic review and meta-analy-
sis of placebo-controlled trials. Clin Infect Dis 2010;50:473-80. 1.358 Steinhart AH et al. Combined budesonide and antibiotic therapy for active Crohn‘s disease: a randomized controlled trial. Gastroenterology 2002;123:33-40. 1.359 Sandborn WJ et al. Medical management of mild to moderate Crohn‘s disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther 2007;26:987- 1003. 1.360 Qu Z et al. Strongyloides colitis is a lethal mimic of ulcerative colitis: the key morphologic differential diagnosis. Hum Pathol 2009;40:572-7. 1.361 Wallis RS. Infectious complications of tumor necrosis blockade. Curr Opin Infect Dis 2009;22:403-9. 1.362 Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008;8:601-11. 1.363 Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents against tumor necrosis factor alpha. Morb Mortal Wkly Rep 2004;53:683-6. 1.364 McMillan A et al. The 2007 European guideline (International Union against Sexually Transmitted Infections/World Health Organization) on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS 2007;18:514-20. 1.365 Davis TW et al. Sexually transmitted infections as a cause of proctitis in men who have sex with men. Dis Colon Rectum 2009;52:507-12. 1.366 Rompalo AM. Diagnosis and treatment of sexually acquired proctitis and proctocolitis: an update. Clin Infect Dis 1999;28(suppl. 1):S84-90. 1.367 Gomez L et al. Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clin Infect Dis 1998;27:695-9. 1.368 Gorschlüter M et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005:75:1-13. 1.369 Cardona AF et al. From case reports to systematic reviews in neutropenic enterocolitis. Eur J Haematol 2005;75:445-6. 1.370 Picardo M et al. Improved management of neutropenic enterocolitis using early ultrasound scan and vigorous medical treatment. Clin Infect Dis 2007;45:403-4. 1.371 Gorschlüter M et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis 2006;6:35. 1.372 Chey WD et al. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25. 1.373 Fuccio L et al. Treatment of Helicobacter pylori infection. Br Med J 2008;337:746-50. 1.374 Kusters JG et al. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Infect 2006;19:449- 90. 1.375 Salles N et al. Current management of Helicobacter pylori infections in the elderly. Expert Rev Anti Infect Ther 2007;5:845-56. 1.376 Suerbaum S et al. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86. 1.377 McColl KE. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604. 1.378 Nakayama Y et al. Helicobacter pylori infection: diagnosis and treatment. Expert Rev Anti Infect Ther 2004;2:599-610. 1.379 Calvet X et al. Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 2009;48:1385-91. 1.380 Gisbert JP et al. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:1921-30. 1.381 Shah R. Dyspepsia and Helicobacter pylori. Br Med J 2007;334;41-3. 1.382 Malfertheiner P et al. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 2003;18:615-25. 1.383 Veldhuyzen van Zanten S et al. Absence of symptomatic benefit of lansoprazole, clarithromycin and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (non ulcer) dyspepsia. Am J Gastroenterol 2003,98:1963-9. 1.384 Gerits MM et al. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006;6:699-709. 1.385 Graham DY et al. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol 2008;5:321-31. 1.386 Fuccio L et al. Meta-analysis: Duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553-62. 1.387 Raoult D et al. Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 2010;16:776- 82. 1.388 Schneider T et al. Whipple‘s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 2008;8:179-90. 1.389 Fenollar F et al. Whipple‘s disease. N Engl J Med 2007;356:55-66. 1.390 Schneider T et al. Whipple‘s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 2008;8:178-90. 1.391 Scheld WM. Whipple disease of the central nervous system. J Infect Dis 2003;188:797-800. 1.392 Maiwald M et al. Cultivation of Tropheryma whipplei from cerebrospinal fluid. J Infect Dis 2003;188: 801-8. 1.393 Kellogg N et al. The evaluation of sexual abuse in children. Pediatrics 2005;116:506-12. 1.394 Kaufman M et al. Care of the adolescent sexual assault victim. Pediatrics 2008;122:462-70. 1.395 Girardet RG et al. Epidemiology of sexually transmitted infections in suspected child victims of sexual assault. Pediatrics 2009;124:79-86. 1.396 Joishy M et al. Do we need to treat vulvovaginitis in prepubertal girls? Br Med J 2005;330:186-8. 1.397 Welch J et al. Rape and sexual assault. Br Med J 2007;334:1154-8. 1.398 Kawsar M et al. Child sexual abuse and sexually transmitted infections: review of joint genito-urinary medicine and paediatric examination practice. Int J STD AIDS 2008;19:349-50. 1.399 Centers for Disease Control and Prevention (CDC). Update to CDC‘s sexually transmitted diseases guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Morb Mortal Wkly Rep 2007;56:332-6. 1.400 Ghanem KG et al. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005;19:351-65. 1.401 Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases. Treatment guidelines 2006. Morb Mortal Wkly Rep 2006;55(RR-11):1-94. 1.402 Greer L et al. Rapid diagnostic methods in sexually transmitted infections. Infect Dis Clin North Am
- Page 1 and 2: TABLE 39A LIST OF PUBLICATIONS REFE
- Page 3 and 4: 1.89 Laupland KB. Vascular and para
- Page 5 and 6: of NICE guidance. Br Med J 2008;337
- Page 7: tions à Clostridium difficile dans
- Page 11 and 12: 1.446 Centers for Disease Control a
- Page 13 and 14: 1.532 Olaison L et al. Enterococcal
- Page 15 and 16: 1.615 Muder RR et al. Isolation of
- Page 17 and 18: 2005;352:865-74. 1.699 Brown-Elliot
- Page 19 and 20: 2009;123:1108-15. 1.782 Ellis MW. A
- Page 21 and 22: 1.873 Korting HC et al. Current top
- Page 23 and 24: 1.970 Thomas RJ et al. Current mana
- Page 25 and 26: of severe respiratory failure. Clin
- Page 27 and 28: 1.1166 Aldape MJ et al. Clostridium
- Page 29 and 30: 2A.36 Wormser GP. Early Lyme diseas
- Page 31 and 32: test methodology. Eur J Clin Microb
- Page 33 and 34: 2B.39 Cookson BD et al. Guidelines
- Page 35 and 36: 2009;15(suppl. 3):7-11. 2B.115 Jaco
- Page 37 and 38: 82. 4A.87 de Smet AM et al. Deconta
- Page 39 and 40: after acute pyelonephritis: a multi
- Page 41 and 42: for intensive care patients with no
- Page 43 and 44: among hospitalized patients. Clin I
- Page 45 and 46: Ther 2006;4:947-52. 5D.1 Demirovic
- Page 47 and 48: 7.38 Meersseman W et al. Invasive a
- Page 49 and 50: 7.121 Walsh TJ et al. All catheter
- Page 51 and 52: nail onychomycosis. J Eur Acad Derm
- Page 53 and 54: 2006. Clin Infect Dis 2006;43:1580-
- Page 55 and 56: 9A.5 Andes D. Pharmacokinetics and
- Page 57 and 58: factor and other newly approved bio
1.309 Zollner-Schwetz I et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis<br />
2008;47:e74-8.<br />
1.310 Guerrant RL et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis<br />
2001;32:331-50.<br />
1.311 DuPont HL. Bacterial diarrhea. N Engl J Med 2009;361:1560-9.<br />
1.312 Musher DM et al. Contagious gastro-intestinal infections. N Engl J Med 2004;351:2417-27.<br />
1.313 Thielman NM et al. Acute infectious diarrhea. N Engl J Med 2004;350:38-47.<br />
1.314 O‘Ryan M et al. An update on management of severe acute infectious gastroenteritis in children. Expert<br />
Rev Anti Infect Ther 2010;8:671-82.<br />
1.315 Phavichitr N et al. Acute gastroenteritis in children: what role for antibacterials? Pediatr Drugs 2003;<br />
5:279-90.<br />
1.316 Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis<br />
Clin North Am 2005;19:585-602.<br />
1.317 Chao HC et al. Bacterial enteric infections in children: etiology, clinical manifestations and antimicrobial<br />
therapy. Expert Rev Anti Infect Ther 2006;4:629-38.<br />
1.318 Elliott EJ. Acute gastroenteritis in children. Br Med J 2007;334:35-40.<br />
1.319 Barclay AR et al. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol<br />
Nutr 2007;45:569-76.<br />
1.320 Moss RL et al. Laparatomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N<br />
Engl J Med 2006;354:2225-34.<br />
1.321 Flake AW. Necrotizing enterocolitis in preterm infants. Is laparatomy necessary? N Engl J Med 2006;<br />
354:2275-76.<br />
1.322 Sears CL et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.<br />
Clin Infect Dis 2008;47:797-803.<br />
1.323 Tribble DR et al. Traveler‘s diarrhea in Thailand: randomized, double-blind trial comparing single-dose<br />
and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007;<br />
44:338-46.<br />
1.324 DuPont HL. Azithromycin for the self-treatment of traveler‘s diarrhea. Clin Infect Dis 2007;44:347-9.<br />
1.325 Shlim DR. Update in traveler‘s diarrhea. Infect Dis Clin North Am 2005;19:137-49.<br />
1.326 Diemert DJ. Prevention and self-treatment of traveler‘s diarrhea. Clin Microbiol Rev 2006;19:583-94.<br />
1.327 DuPont HL. Therapy for and prevention of traveler‘s diarrhea. Clin Infect Dis 2007;45(suppl. 1):S78-<br />
84.<br />
1.328 Sanders JW et al. Azithromycin and loperamide are similar to levofloxacin and loperamide for the<br />
treatment of traveler‘s diarrhea in military personnel in Turkey. Clin Infect Dis 2007;45:294-301.<br />
1.329 Okhuysen PC. Current concepts in traveler‘s diarrhea: epidemiology, antimicrobial resistance and<br />
treatment. Curr Opin Infect Dis 2005;18:522-6.<br />
1.330 Leggat PA et al. Thavellers‘ diarrhoea: health advice for travellers. Travel Med Infect Dis 2004;2:17-<br />
22.<br />
1.331 Koo HL et al. Current and future developments in traveler‘s diarrhea therapy. Expert Rev Anti Infect<br />
Ther 2006;4:417-27.<br />
1.332 Yates J. Traveler‘s diarrhea. Am Fam Physician 2005;71:2095-100.<br />
1.333 Al-Abri SS et al. Traveller‘s diarrhoea. Lancet Infect Dis 2005;5:349-60.<br />
1.334 Adachi JA et al. Empirical antimicrobial therapy for traveler‘s diarrhea. Clin Infect Dis 2000;31:1079-<br />
83.<br />
1.335 Sack DA et al. Cholera. Lancet 2004;363:223-33.<br />
1.336 Kartalija M et al. Diarrhea and AIDS in the era of highly active antiretroviral therapy. Clin Infect Dis<br />
1999;28:701-7.<br />
1.337 Peghini PL et al. Improvement of chronic diarrhea after treatment for intestinal spirochetosis. Dig Dis<br />
Sci 2000;45:1006-10.<br />
1.338 Brooke CJ et al. In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrob<br />
Agents Chemother 2003;47:2354-7.<br />
1.339 Koteish A et al. Colonic spirochetosis in children and adults. Am J Clin Pathol 2003;120:828-32.<br />
1.340 Evans MR et al. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter<br />
infection. Clin Infect Dis 2009;48:1500-6.<br />
1.341 Ternhag A et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused<br />
by infection with Campylobacter species. Clin Infect Dis 2007;44:696-700.<br />
1.342 Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimi-crobial<br />
resistance: playing chicken. Clin Infect Dis 2007;44:701-3.<br />
1.343 Lecuit M et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N<br />
Engl J Med 2004;350:239-48.<br />
1.344 Feodoroff FB et al. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.<br />
Clin Microbiol Infect 2009;15:188-92.<br />
1.345 Rogers TJ et al. Therapeutic strategies for shigatoxin-producing Escherichia coli infections. Expert<br />
Rev Anti Infect Ther 2009;7:683-6.<br />
1.346 Palermos MS et al. Hemolytic uremic syndrome: pathogenesis and update of interventions. Expert<br />
Rev Anti Infect Ther 2009;7:697-707.<br />
1.347 Goldwater PN. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic<br />
uremic syndrome. Expert Rev Anti Infect Ther 2007;5:653-63.<br />
1.348 Tarr PI et al. Shiga toxin producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;<br />
365:1073-86.<br />
1.349 Thorpe CM. Shiga toxin producing Escherichia coli infection. Clin Infect Dis 2004;38:1298-303.<br />
1.350 Tzipori S et al. Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome.<br />
Clin Microbiol Rev 2004;17:926-41.<br />
1.351 Orth D et al. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.<br />
Expert Rev Anti Infect Ther 2008;6:101-8.<br />
1.352 Majowicz SE et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis<br />
2010;50:882-9.<br />
1.353 Saha D et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med 2006;354:<br />
2452-62.<br />
1.354 Abraham C et al. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.<br />
1.355 Eckburg PB et al. The role of microbes in Crohn‘s disease. Clin Infect Dis 2007;44:256-62.<br />
1.356 Collins P et al. Ulcerative colitis: diagnosis and management. Br Med J 2006;333:340-3.<br />
1.357 Feller M et al. Long-term antibiotic treatment for Crohn‘s disease: systematic review and meta-analy-
Change language